ESLA
Estrella Immunopharma Inc.
NASDAQ: ESLA · HEALTHCARE · BIOTECHNOLOGY
$1.64
+11.56% today
Updated 2026-04-30
Market cap
$67.41M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
Estrella Immunopharma Inc. (ESLA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-268.50%
ROA
-258.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-733693.00 | — | — | — |
| 2021 | $0.00 | $-1.69M | — | — | — |
| 2022 | $0.00 | $-996104.00 | — | — | — |
| 2023 | $0.00 | $-7.31M | — | — | — |
| 2024 | — | $-8.85M | — | — | — |
| 2025 | $0.00 | $-13.06M | — | — | — |